Shahzad Malik - Net Worth and Insider Trading
Shahzad Malik Net Worth
The estimated net worth of Shahzad Malik is at least $2 Million dollars as of 2024-04-23. Shahzad Malik is the Director, 10% Owner of Conatus Pharmaceuticals Inc and owns about 4,054,927 shares of Conatus Pharmaceuticals Inc (CNAT) stock worth over $2 Million. Shahzad Malik is the Director of Iterum Therapeutics PLC and owns about 57,877 shares of Iterum Therapeutics PLC (ITRM) stock worth over $91,446. Shahzad Malik is also the Director of Aravive Inc and owns about 271,794 shares of Aravive Inc (ARAV) stock worth over $10,899. Besides these, Shahzad Malik also holds Agenus Inc (AGEN) . Details can be seen in Shahzad Malik's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Shahzad Malik has not made any transactions after 2018-05-30 and currently still holds the listed stock(s).
Transaction Summary of Shahzad Malik
Shahzad Malik Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Shahzad Malik owns 7 companies in total, including Acutus Medical Inc (AFIB) , Iterum Therapeutics PLC (ITRM) , and Aravive Inc (ARAV) among others .
Click here to see the complete history of Shahzad Malik’s form 4 insider trades.
Insider Ownership Summary of Shahzad Malik
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AFIB | Acutus Medical Inc | 2020-08-05 | director |
| ITRM | Iterum Therapeutics PLC | 2019-06-13 | director |
| ARAV | Aravive Inc | 2019-09-12 | director |
| AXNX | Axonics Inc | 2018-10-30 | director & 10 percent owner |
| HSTO | Histogen Inc | 2013-07-24 | director & 10 percent owner |
| AGEN | Agenus Inc | 2015-04-29 | director |
| EBS | Emergent BioSolutions Inc | 2007-06-14 | director |
Shahzad Malik Latest Holdings Summary
Shahzad Malik currently owns a total of 4 stocks. Among these stocks, Shahzad Malik owns 4,054,927 shares of Conatus Pharmaceuticals Inc (CNAT) as of July 30, 2013, with a value of $2 Million and a weighting of 95.69%. Shahzad Malik owns 57,877 shares of Iterum Therapeutics PLC (ITRM) as of May 30, 2018, with a value of $91,446 and a weighting of 3.85%. Shahzad Malik also owns 271,794 shares of Aravive Inc (ARAV) as of March 17, 2017, with a value of $10,899 and a weighting of 0.46%. The other 1 stocks Agenus Inc (AGEN) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Shahzad Malik
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CNAT | Conatus Pharmaceuticals Inc | 2013-07-30 | 4,054,927 | 0.56 | 2,270,759 |
| ITRM | Iterum Therapeutics PLC | 2018-05-30 | 57,877 | 1.58 | 91,446 |
| ARAV | Aravive Inc | 2017-03-17 | 271,794 | 0.04 | 10,899 |
| AGEN | Agenus Inc | 2015-04-29 | 0 | 6.44 | 0 |
Holding Weightings of Shahzad Malik
Shahzad Malik Form 4 Trading Tracker
According to the SEC Form 4 filings, Shahzad Malik has made a total of 0 transactions in Conatus Pharmaceuticals Inc (CNAT) over the past 5 years. The most-recent trade in Conatus Pharmaceuticals Inc is the sale of 535 shares on July 30, 2013, which brought Shahzad Malik around $5,885.
According to the SEC Form 4 filings, Shahzad Malik has made a total of 0 transactions in Iterum Therapeutics PLC (ITRM) over the past 5 years. The most-recent trade in Iterum Therapeutics PLC is the acquisition of 15,799 shares on May 30, 2018, which cost Shahzad Malik around $3 Million.
According to the SEC Form 4 filings, Shahzad Malik has made a total of 0 transactions in Aravive Inc (ARAV) over the past 5 years. The most-recent trade in Aravive Inc is the sale of 80,612 shares on March 17, 2017, which brought Shahzad Malik around $9 Million.
More details on Shahzad Malik's insider transactions can be found in the Insider Trading History of Shahzad Malik table.Insider Trading History of Shahzad Malik
- 1
Shahzad Malik Trading Performance
GuruFocus tracks the stock performance after each of Shahzad Malik's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Shahzad Malik is -16.21%. GuruFocus also compares Shahzad Malik's trading performance to market benchmark return within the same time period. The performance of stocks bought by Shahzad Malik within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Shahzad Malik's insider trading performs compared to the benchmark.
Performance of Shahzad Malik
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -12.18 | -16.21 | -48.4 | -44.45 | -41.14 | -50.8 |
| Relative Return to S&P 500(%) | -11.97 | -22.71 | -49.73 | -46.83 | -46.86 | -66.38 |
Shahzad Malik Ownership Network
Ownership Network List of Shahzad Malik
Ownership Network Relation of Shahzad Malik
Shahzad Malik Owned Company Details
What does Acutus Medical Inc do?
Who are the key executives at Acutus Medical Inc?
Shahzad Malik is the director of Acutus Medical Inc. Other key executives at Acutus Medical Inc include Interim CFO Takeo Mukai , SVP & Global Sales Kevin Mathews , and Chief People Officer Charlie Piscitello .
Acutus Medical Inc (AFIB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Acutus Medical Inc (AFIB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acutus Medical Inc (AFIB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Acutus Medical Inc (AFIB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acutus Medical Inc Insider Transactions
Shahzad Malik Mailing Address
Above is the net worth, insider trading, and ownership report for Shahzad Malik. You might contact Shahzad Malik via mailing address: 2273 Research Blvd, Suite 400, Rockville Md 20850.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
